All In Biotech

Drug Trial Radar · NCT07134231

Clinical Study to Evaluate the Anti-cavity Efficacy of Three Dentifrices: An In Situ Model

In Situ Evaluation of the Anti-cavity Efficacy of Three Dentifrices Using an Intra-oral Enamel Demineralization-Remineralization Model

Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

36

Actual

Start

Oct 9, 2025

Primary completion

Dec 11, 2025

Study completion Dec 11, 2025

Sponsor

Lead sponsor
Colgate PalmoliveIndustry
Sponsor type
Industry
Collaborators
Federal University of Alagoas
First posted
Aug 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Clinical study to evaluate the anti-cavity effectiveness of three dentrifices using an intra-oral enamel Demineralization and Remineralization In-Situ Model. This is a six-week duration, Phase III, single-center, triple-blind crossover study. Thirty-six healthy adults will be randomly allocated to three groups for the treatment phases, which are interspersed with washout periods.

Conditions

  • Demineralization
  • Remineralization
  • Dental Cavity
  • Enamel Lesions

Interventions

  • Fluoride free toothpaste in a chalk baseDrug

    Fluoride free toothpaste in a chalk base with herbal ingredients

  • Fluoride ToothpasteDrug

    Fluoride toothpaste containing 1000 ppm MFP and 1.5% arginine in a PCC/RNCC base

  • Fluoride free toothpaste in a PCC/RNCC baseDrug

    Fluoride free toothpaste in a PCC/RNCC base

  • ToothbrushDevice

    A commercially available adult soft bristle toothbrush

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Microhardness changeTime frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Federal University of Alagoas

    Maceió, Alagoas, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.